$MTWO
M2i Global, Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224016788 Filed on April 26, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.349M $675.2K
YoY Change 203.74% 2050.89%
Operating Profit -$1.349M -$675.2K
YoY Change 203.74% 2312.15%
Interest Expense $23.91K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$25.78K -$23.91K
YoY Change 22512.28%
Pretax Income -$1.375M -$699.1K
YoY Change 154.96% -2597.59%
Income Tax
% Of Pretax Income
Net Earnings -$1.375M -$699.1K
YoY Change 154.96% 2397.59%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 464.3M shares 513.8M shares 514.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $72.51K $23.23K $48.20K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $127.9K $104.6K $48.20K
YoY Change -58.51% 664.24% 247.22%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $127.9K $104.6K $48.20K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $127.9K $104.6K $48.20K
YoY Change -58.51% -11.36% -61.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.474M $1.296M $1.087M
YoY Change 1256.69% 810.58% 789.28%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.474M $1.296M $1.087M
Total Long-Term Liabilities
Total Liabilities $2.474M $1.296M $1.087M
YoY Change 1256.69% 810.58% 789.28%
SHAREHOLDERS EQUITY
Retained Earnings -$4.188M -$2.813M -$2.114M
YoY Change 506.12% -1953.72% -1808.09%
Common Stock $502.2K $464.3K $514.3K
YoY Change -2.35% 6435.31% 7139.04%
Preferred Stock
YoY Change
Treasury Stock (at cost) $435.0K $435.0K $435.0K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$2.346M -$1.192M -$1.039M
YoY Change
Total Liabilities & Shareholders Equity $127.9K $104.6K $48.20K
YoY Change -58.51% -11.36% -61.7%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.375M -$699.1K
YoY Change 154.96% 2397.59%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$590.9K
YoY Change 115994.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $566.0K
YoY Change 18917.14%
NET CHANGE
Cash From Operating Activities -$590.9K
Cash From Investing Activities
Cash From Financing Activities $566.0K
Net Change In Cash -$24.97K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$590.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Revenues
Revenues
usd
CY2023Q1 us-gaap Legal Fees
LegalFees
usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2024Q1 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 MTWO Proceeds From Cash Received For Shares To Be Issued
ProceedsFromCashReceivedForSharesToBeIssued
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
333-229748
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
M2i GLOBAL, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1904036
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
885 Tahoe Blvd.
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Incline Village
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89451
CY2024Q1 dei City Area Code
CityAreaCode
(775)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
909-6000
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
100000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
100000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
464333691 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
464333691 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
514333691 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
514333691 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
464334 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
514334 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
435000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
435000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1591990 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
995541 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2813021 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2113921 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1191597 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1038946 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104556 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48197 usd
CY2023Q1 us-gaap Revenues
Revenues
3400 usd
CY2024Q1 us-gaap Legal Fees
LegalFees
561710 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
675185 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
31391 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-675185 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-27991 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
23914 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23914 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-699100 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27991 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
513784240 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7105357 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1038946 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
551450 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-699100 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1191597 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3601 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3601 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-27991 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24390 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-24390 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-699100 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-27991 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
11183 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19927 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-200 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
123106 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
617 usd
CY2023Q1 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
16500 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-590921 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
509 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3485 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3485 usd
CY2024Q1 MTWO Proceeds From Cash Received For Shares To Be Issued
ProceedsFromCashReceivedForSharesToBeIssued
551450 usd
CY2024Q1 MTWO Payment For Cancelled Shares
PaymentForCancelledShares
5000 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19500 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2976 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
565950 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2976 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24970 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48197 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
114 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23226 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
114 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
17351 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_z0L3LdAV3O2k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_z3WIuPCAb2c3">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
50000000 shares
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
553100 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
32100000 shares
CY2024Q2 us-gaap Notes Payable
NotesPayable
104160 usd
CY2024Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
26227 usd
CY2024Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
8265 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1299 pure
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
255000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
250000 usd

Files In Submission

Name View Source Status
0001493152-24-016788-index-headers.html Edgar Link pending
0001493152-24-016788-index.html Edgar Link pending
0001493152-24-016788.txt Edgar Link pending
0001493152-24-016788-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mtwo-20240229.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
mtwo-20240229_cal.xml Edgar Link unprocessable
mtwo-20240229_def.xml Edgar Link unprocessable
mtwo-20240229_lab.xml Edgar Link unprocessable
mtwo-20240229_pre.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable